Rett syndrome is a neurodevelopmental disorder caused by mutations in the MECP2 gene. We investigated the genetic basis of disease in a female patient with a Rett-like clinical. Karyotype analysis revealed a pericentric inversion in the X chromosome −46,X,inv(X)(p22.1q28), with breakpoints in the cytobands where the MECP2 and CDKL5 genes are located. FISH analysis revealed that the MECP2 gene is not dislocated by the inversion. However, and in spite of a balanced pattern of X inactivation, this patient displayed hypomethylation and an overexpression of the MECP2 gene at the mRNA level in the lymphocytes (mean fold change: 2.55 ± 0.38) in comparison to a group of control individuals; the expression of the CDKL5 gene was similar to that of controls (mean fold change: 0.98 ± 0.10). No gains or losses were detected in the breakpoint regions encompassing known or suspected transcription regulatory elements. We propose that the de-regulation of MECP2 expression in this patient may be due to alterations in long-range genomic interactions caused by the inversion and hypothesize that this type of epigenetic de-regulation of the MECP2 may be present in other RTT-like patients.
Introduction
Rett syndrome (RTT) is a neurodevelopmental disorder characterized by an early regression followed by stagnation in growth and development, leading to mental retardation, stereotypies and motor apraxia that may be associated with epilepsy and with dysautonomic features, including disturbed breathing, sleep and gastrointestinal motility (Hagberg et al., 1983; Rett, 1966) . RTT is caused by mutations in the MECP2 gene, encoding a methyl-CpG binding protein thought to be involved in transcriptional regulation (Amir et al., 1999; Hoffbuhr et al., 2001; Philippe et al., 2006) . Mutations in this gene are present in more than 90% of patients that fulfill the diagnostic criteria, and with lesser frequency in patients with so-called variant forms of the disease, that do not comply with all these criteria (Amir et al., 1999; Hoffbuhr et al., 2001; Philippe et al., 2006) .
The most frequent mutations in MECP2 are point mutations, small insertions or deletions. The genotype of patients without one of these mutations has also been investigated and some cases with gross rearrangements involving the MECP2 gene were found, usually large deletions. In boys, MECP2 duplication is the rare cause of a severe encephalopathy with recurrent infections, severe mental retardation, microcephaly and epilepsy (Ramocki et al., 2009; Van Esch et al., 2005) . MECP2 duplication has also been described in a
